Novo Nordisk, the maker of Ozempic and Wegovy, previously told Fox News Digital that it is "humbling to see how Ozempic and Wegovy have already helped so many Americans." CLICK HERE TO DOWNLOAD THE FOX NEWS APP "We are proud of the work our scientists have done to advance innovation and improve the lives of people with chronic diseases, including diabetes and obesity," a spokesperson added
Effectiveness on Hard Cardiovascular and Renal Outcomes The great interest towards GLP-1RAs has been advocated by the beneficial effects of this class of medications on major cardiovascular outcomes, mortality and, to a lesser extent, renal outcomes
Adjusting Dosage: Based on response and under medical supervision
Involving 2,339 participants with obesity, the study showcased impressive weight loss achievements, especially at higher doses
Any persistent or concerning changes in sexual function warrant proper medical evaluation to identify underlying causes